• Resize textA -AA +
  • Dark Mode Icon

AAV mediated genome engineering with a bypass coagulation factor alleviates the bleeding phenotype in a murine model of hemophilia B.

AAV mediated genome engineering with a bypass coagulation factor alleviates the bleeding phenotype in a murine model of hemophilia B.

Sarangi, P., Kumar, N., Sambasivan, R., Ramalingam, S., Amit, S., Chandra, D., & Jayandharan, G. R. (2024). AAV mediated genome engineering with a bypass coagulation factor alleviates the bleeding phenotype in a murine model of hemophilia B. Thrombosis Research, 238. DOI: 10.1016/j.thromres.2024.04.031